The FDA’s mid-November decision on Biohaven’s spinocerebellar ataxia treatment could redefine rare disease approvals and ...
When doctors told Alexis Penn that her then-15-year-old daughter, Emily, would likely need a wheelchair by her early 20s, she refused to let fear take over. “So many people facing disabilities have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback